These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9209452)

  • 1. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
    Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
    Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    Cao Y; Qin L; Zhang L; Safrit J; Ho DD
    N Engl J Med; 1995 Jan; 332(4):201-8. PubMed ID: 7808485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of in vitro suppression of human immunodeficiency virus type 1 (HIV-1) replication mediated by CD8+ T lymphocytes of asymptomatic HIV-1 carriers by staphylococcal enterotoxin B and phorbol esters through induction of tumor necrosis factor alpha.
    Kubo M; Ohashi T; Fujii M; Oka S; Iwamoto A; Harada S; Kannagi M
    J Virol; 1997 Oct; 71(10):7560-6. PubMed ID: 9311836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High SDF-1 expression in HIV-1 carriers does not correlate with CD8+ T-cell-mediated suppression of viral replication.
    Ohashi T; Arai M; Kato H; Kubo M; Fujii M; Yamamoto N; Iwamoto A; Kannagi M
    Virology; 1998 May; 244(2):467-72. PubMed ID: 9601514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.
    Daar ES; Moudgil T; Meyer RD; Ho DD
    N Engl J Med; 1991 Apr; 324(14):961-4. PubMed ID: 1823118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
    Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
    N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of matrix metalloproteinases in human immunodeficiency virus type 1-induced replication by clinical Mycobacterium avium isolates.
    Dezzutti CS; Swords WE; Guenthner PC; Sasso DR; Wahl LM; Drummond AH; Newman GW; King CH; Quinn FD; Lal RB
    J Infect Dis; 1999 Oct; 180(4):1142-52. PubMed ID: 10479141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
    Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.
    Barker E; Bossart KN; Locher CP; Patterson BK; Levy JA
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2953-62. PubMed ID: 9000085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of CD8+ cells on isolation and replication of HIV-1].
    Tateno Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):411-22. PubMed ID: 7927170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.
    Planelles V; Bachelerie F; Jowett JB; Haislip A; Xie Y; Banooni P; Masuda T; Chen IS
    J Virol; 1995 Sep; 69(9):5883-9. PubMed ID: 7637036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of class I major histocompatibility complex-restricted and -unrestricted suppression of human immunodeficiency virus type 1 replication by CD8+ T lymphocytes.
    Ohashi T; Kubo M; Kato H; Iwamoto A; Takahashi H; Fujii M; Kannagi M
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():209-216. PubMed ID: 9934704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sources.
    Lu W; Andrieu JM
    J Virol; 1992 Jan; 66(1):334-40. PubMed ID: 1727492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CD8-positive lymphocytes in the control of HIV-1 infection of peripheral blood mononuclear cells.
    Bagasra O; Pomerantz RJ
    Immunol Lett; 1993 Feb; 35(2):83-92. PubMed ID: 8509156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.
    Vicenzi E; Dimitrov DS; Engelman A; Migone TS; Purcell DF; Leonard J; Englund G; Martin MA
    J Virol; 1994 Dec; 68(12):7879-90. PubMed ID: 7966578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1.
    Semenzato G; Agostini C; Ometto L; Zambello R; Trentin L; Chieco-Bianchi L; De Rossi A
    Blood; 1995 May; 85(9):2308-14. PubMed ID: 7727764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.